Phase II clinical development of new drugs [Documento eletrónico] / Naitee Ting ... [et al.]
Language: eng.Country: SG - Singapura.Publication: Singapore : Springer , 2017Description: XVII, 241 p. : il.ISBN: 978-981-10-4194-5.Series: ICSA Book Series in StatisticsSubject - Topical Name: Estatística | Tecnologia farmacêutica | Gestão Online Resources:Click here to access onlineItem type | Current library | Collection | Call number | Copy number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|---|---|
E-Books | Biblioteca NOVA FCT Online | Não Ficção | QA276.SPR FCT 97695 (Browse shelf(Opens below)) | 1 | Available |
Browsing Biblioteca NOVA FCT shelves, Shelving location: Online, Collection: Não Ficção Close shelf browser (Hides shelf browser)
QA276.SPR FCT 97492 Basic elements of computational statistics | QA276.SPR FCT 97682 Data science, innovative developments in data analysis and clustering | QA276.SPR FCT 97689 Modelling with the master equation, solution methods and applications in social and natural sciences | QA276.SPR FCT 97695 Phase II clinical development of new drugs | QA276.SPR FCT 97702 Statistical modeling for degradation data | QA276.SPR FCT 97746 Multivariate methods and forecasting with IBM® SPSS® statistics | QA276.SPR FCT 97747 Functional statistics and related fields |
Colocação: Online
This book focuses on how to appropriately plan and develop a Phase II program, and how to design Phase II clinical trials and analyze their data. It provides a comprehensive overview of the entire drug development process and highlights key questions that need to be addressed for the successful execution of Phase II, so as to increase its success in Phase III and for drug approval. Lastly it warns project team members of the common potential pitfalls and offers tips on how to avoid them.
There are no comments on this title.